Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.

about

Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia

P2860

Q58554489-4D0D9E96-FEE8-4168-898D-1C3614EB1F5D

P2860

Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.

Item

http://www.wikidata.org/entity/Q38675384

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.

@en

type

Item

label

Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.

@en

prefLabel

Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.

@en

P1476

Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.

@en

P2093

Feng Jianguo

http://www.w3.org/2001/XMLSchema#string

Gu Linhui

http://www.w3.org/2001/XMLSchema#string

Jiang Ruibin

http://www.w3.org/2001/XMLSchema#string

Ling Yutian

http://www.w3.org/2001/XMLSchema#string

Sheng Huaying

http://www.w3.org/2001/XMLSchema#string

Wan Danying

http://www.w3.org/2001/XMLSchema#string

Zhu Chihong

http://www.w3.org/2001/XMLSchema#string

P2860

Transglutaminases: nature's biological glues

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Cancer statistics, 2016

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

Redox regulation of transglutaminase 2 activity.

Transglutaminases: crosslinking enzymes with pleiotropic functions.

Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.

The 7th lung cancer TNM classification and staging system: Review of the changes and implications.

Transglutaminase 2 expression predicts progression free survival in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor

P304

45577-45584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17374

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28715877

http://www.w3.org/2001/XMLSchema#string

P932

5542209

http://www.w3.org/2001/XMLSchema#string

Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.

about

P2860

P2860

Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932